advertisement
Japanese Journal of Ophthalmology 17
Showing records 1 to 17 | Display all abstracts in Japanese Journal of Ophthalmology112512 Additive effects of brimonidine tartrate 0.1%/brinzolamide 1% fixed-dose combination in prostaglandin analog-treated Japanese glaucoma patients
Sakata R
Japanese Journal of Ophthalmology 2023; 67: 668-677
112507 Lens factor as an underlying mechanism in primary angle closure with gonioscopically-visualized ciliary body processes
Tekcan H
Japanese Journal of Ophthalmology 2023; 67: 678-684
111879 Prediction of visual field progression in glaucoma: existing methods and artificial intelligence
Asaoka R
Japanese Journal of Ophthalmology 2023; 67: 546-559
112379 Persistence of the carteolol hydrochloride/latanoprost fixed-combination ophthalmic solution, compared with the other β-blocker/prostanoid FP receptor agonist fixed-combination ophthalmic solutions
Kashiwagi K
Japanese Journal of Ophthalmology 2023; 67: 658-667
112283 Surgical safety and efficacy of a multi-stent system, the comet stent, in Baerveldt glaucoma implant surgery: a prospective pilot study
Manabe SI
Japanese Journal of Ophthalmology 2023; 67: 685-692
111879 Prediction of visual field progression in glaucoma: existing methods and artificial intelligence
Murata H
Japanese Journal of Ophthalmology 2023; 67: 546-559
112283 Surgical safety and efficacy of a multi-stent system, the comet stent, in Baerveldt glaucoma implant surgery: a prospective pilot study
Hirata A
Japanese Journal of Ophthalmology 2023; 67: 685-692
112379 Persistence of the carteolol hydrochloride/latanoprost fixed-combination ophthalmic solution, compared with the other β-blocker/prostanoid FP receptor agonist fixed-combination ophthalmic solutions
Ouchi K
Japanese Journal of Ophthalmology 2023; 67: 658-667
112512 Additive effects of brimonidine tartrate 0.1%/brinzolamide 1% fixed-dose combination in prostaglandin analog-treated Japanese glaucoma patients
Mizoue S
Japanese Journal of Ophthalmology 2023; 67: 668-677
112507 Lens factor as an underlying mechanism in primary angle closure with gonioscopically-visualized ciliary body processes
Mangan MS; Celik G
Japanese Journal of Ophthalmology 2023; 67: 678-684
112283 Surgical safety and efficacy of a multi-stent system, the comet stent, in Baerveldt glaucoma implant surgery: a prospective pilot study
Akagi T
Japanese Journal of Ophthalmology 2023; 67: 685-692
112379 Persistence of the carteolol hydrochloride/latanoprost fixed-combination ophthalmic solution, compared with the other β-blocker/prostanoid FP receptor agonist fixed-combination ophthalmic solutions
Shibasaki Y
Japanese Journal of Ophthalmology 2023; 67: 658-667
112512 Additive effects of brimonidine tartrate 0.1%/brinzolamide 1% fixed-dose combination in prostaglandin analog-treated Japanese glaucoma patients
Yoshikawa K
Japanese Journal of Ophthalmology 2023; 67: 668-677
112283 Surgical safety and efficacy of a multi-stent system, the comet stent, in Baerveldt glaucoma implant surgery: a prospective pilot study
Hayashi K
Japanese Journal of Ophthalmology 2023; 67: 685-692
112379 Persistence of the carteolol hydrochloride/latanoprost fixed-combination ophthalmic solution, compared with the other β-blocker/prostanoid FP receptor agonist fixed-combination ophthalmic solutions
Suginaka M
Japanese Journal of Ophthalmology 2023; 67: 658-667
112507 Lens factor as an underlying mechanism in primary angle closure with gonioscopically-visualized ciliary body processes
Imamoglu S
Japanese Journal of Ophthalmology 2023; 67: 678-684
112512 Additive effects of brimonidine tartrate 0.1%/brinzolamide 1% fixed-dose combination in prostaglandin analog-treated Japanese glaucoma patients
Adachi M; Ohkubo S; Hamada N; Naito T; Muramatsu T; Hara T; Asato R; Aihara M
Japanese Journal of Ophthalmology 2023; 67: 668-677
